Spots Global Cancer Trial Database for mass spectrometry
Every month we try and update this database with for mass spectrometry cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate | NCT00459407 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... | defined green t... placebo immunohistochem... immunoenzyme te... laboratory biom... biopsy mass spectromet... high performanc... | 18 Years - | National Cancer Institute (NCI) | |
| Pharmacokinetics of Dactinomycin in Young Patients With Cancer | NCT00900354 | Unspecified Chi... | molecular genet... mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Mass Spectral Fingerprinting in Lung Cancer | NCT02781857 | Lung Cancer | No intervention | 18 Years - 85 Years | University of Zurich | |
| ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00770471 | Brain and Centr... | temozolomide veliparib DNA methylation... gene expression... mutation analys... proteomic profi... high performanc... immunoenzyme te... laboratory biom... mass spectromet... pharmacogenomic... pharmacological... adjuvant therap... radiation thera... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors | NCT00547131 | Brain and Centr... Metastatic Canc... | temozolomide laboratory biom... liquid chromato... mass spectromet... pharmacological... conventional su... stereotactic ra... | 18 Years - 120 Years | City of Hope Medical Center | |
| High-Dose Methotrexate in Treating Young Patients With Solid Tumors | NCT00513981 | Brain and Centr... Sarcoma Unspecified Chi... | leucovorin calc... methotrexate mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Fatigue in Breast Cancer Survivors | NCT00972400 | Breast Cancer Cancer Survivor Fatigue Psychosocial Ef... | protein analysi... laboratory biom... mass spectromet... questionnaire a... assessment of t... cognitive asses... quality-of-life... | - | National Cancer Institute (NCI) | |
| Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00825201 | Ovarian Cancer Peritoneal Cavi... Unspecified Adu... | paclitaxel albu... liquid chromato... mass spectromet... pharmacological... laboratory biom... | 19 Years - | City of Hope Medical Center | |
| Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate | NCT01582009 | Clear Cell Rena... Recurrent Renal... Stage III Renal... Stage IV Renal ... | panobinostat everolimus laboratory biom... pharmacological... liquid chromato... mass spectromet... enzyme-linked i... immunohistochem... | 18 Years - | Roswell Park Cancer Institute | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer | NCT01004796 | Breast Cancer | cytogenetic ana... microarray anal... mutation analys... immunohistochem... immunologic tec... mass spectromet... | - 120 Years | National Cancer Institute (NCI) | |
| Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma | NCT01387724 | Neuroblastoma | RNA analysis polymerase chai... protein express... proteomic profi... western blottin... enzyme-linked i... immunohistochem... laboratory biom... liquid chromato... mass spectromet... | 1 Year - 10 Years | Children's Oncology Group | |
| Mass Spectrometry in Single Bladder Cancer Cells | NCT03639090 | Bladder Cancer | mass spectromet... | 30 Years - 99 Years | University of Oklahoma | |
| Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers | NCT00984919 | Prostate Cancer | high performanc... laboratory biom... mass spectromet... | 40 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer | NCT00898742 | Head and Neck C... | DNA and tissue ... reverse transcr... mass spectromet... | - | Vanderbilt-Ingram Cancer Center | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma | NCT01365962 | Sarcoma | gene expression... immunohistochem... laboratory biom... mass spectromet... | - | Children's Oncology Group | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer | NCT01004796 | Breast Cancer | cytogenetic ana... microarray anal... mutation analys... immunohistochem... immunologic tec... mass spectromet... | - 120 Years | National Cancer Institute (NCI) | |
| Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia | NCT01385150 | Leukemia | mutation analys... protein analysi... laboratory biom... liquid chromato... mass spectromet... | 17 Years - 60 Years | Eastern Cooperative Oncology Group | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors | NCT00709020 | Breast Cancer Cancer Survivor | white button mu... flow cytometry high performanc... laboratory biom... mass spectromet... pharmacogenomic... pharmacological... | 21 Years - | City of Hope Medical Center | |
| Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma | NCT05536700 | Multiple Myelom... | 18 Years - 85 Years | Institute of Hematology & Blood Diseases Hospital, China | ||
| Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00714181 | Unspecified Adu... | hydroxychloroqu... temozolomide TdT-mediated dU... western blottin... electron micros... high performanc... immunoenzyme te... immunohistochem... laboratory biom... mass spectromet... pharmacological... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors | NCT00550901 | Unspecified Adu... | cisplatin dexrazoxane hyd... high performanc... laboratory biom... mass spectromet... pharmacological... | 18 Years - | City of Hope Medical Center | |
| Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers | NCT00984919 | Prostate Cancer | high performanc... laboratory biom... mass spectromet... | 40 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer | NCT00569543 | Breast Cancer | high performanc... laboratory biom... mass spectromet... medical chart r... | 19 Years - | University of Nebraska | |
| SurgicAl Metabolic Phenotyping Longitudinal Evaluation Study | NCT01378013 | Colon Cancer Breast Cancer Trauma Inflammatory Bo... Hernia | 18 Years - | Imperial College London | ||
| Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00714181 | Unspecified Adu... | hydroxychloroqu... temozolomide TdT-mediated dU... western blottin... electron micros... high performanc... immunoenzyme te... immunohistochem... laboratory biom... mass spectromet... pharmacological... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma | NCT01366170 | Lymphoma | microarray anal... protein express... western blottin... flow cytometry immunohistochem... laboratory biom... mass spectromet... | - 20 Years | Children's Oncology Group | |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases | NCT01234740 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... Tumors Metastat... Adult Anaplasti... | bafetinib microdialysis pharmacological... liquid chromato... mass spectromet... laboratory biom... protein express... western blottin... immunohistochem... therapeutic con... | 18 Years - | City of Hope Medical Center | |
| Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer | NCT00691509 | Breast Cancer | gene expression... polymorphism an... high performanc... laboratory biom... mass spectromet... questionnaire a... | - 75 Years | National Cancer Institute (NCI) | |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases | NCT01234740 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... Tumors Metastat... Adult Anaplasti... | bafetinib microdialysis pharmacological... liquid chromato... mass spectromet... laboratory biom... protein express... western blottin... immunohistochem... therapeutic con... | 18 Years - | City of Hope Medical Center | |
| Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00575393 | Lung Cancer | gold sodium thi... gene expression... fluorine F 18 f... mass spectromet... pharmacological... | 18 Years - 120 Years | Mayo Clinic | |
| Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia | NCT01383447 | Philadelphia Ch... Recurrent Adult... | entinostat imatinib mesyla... laboratory biom... pharmacological... western blottin... immunohistochem... flow cytometry polymerase chai... high performanc... mass spectromet... | 18 Years - | National Cancer Institute (NCI) | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery | NCT00466505 | Colorectal Canc... | cetuximab celecoxib proteomic profi... immunohistochem... laboratory biom... mass spectromet... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Mass Spectral Fingerprinting in Lung Cancer | NCT02781857 | Lung Cancer | No intervention | 18 Years - 85 Years | University of Zurich | |
| Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer | NCT00892515 | Breast Cancer Healthy, no Evi... | exercise interv... counseling inte... gas chromatogra... immunoenzyme te... immunologic tec... laboratory biom... mass spectromet... physiologic tes... questionnaire a... survey administ... dual x-ray abso... magnetic resona... study of high r... | 18 Years - 35 Years | Abramson Cancer Center at Penn Medicine | |
| Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery | NCT01340599 | Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | defined green t... placebo immunohistochem... immunoenzyme te... questionnaire a... therapeutic con... high performanc... mass spectromet... | 45 Years - 75 Years | Case Comprehensive Cancer Center | |
| Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery | NCT00436566 | Breast Cancer Cardiac Toxicit... | trastuzumab cyclophosphamid... doxorubicin hyd... lapatinib ditos... paclitaxel gene expression... reverse transcr... fluorophotometr... laboratory biom... mass spectromet... adjuvant therap... quality-of-life... | 18 Years - 120 Years | Mayo Clinic | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00825201 | Ovarian Cancer Peritoneal Cavi... Unspecified Adu... | paclitaxel albu... liquid chromato... mass spectromet... pharmacological... laboratory biom... | 19 Years - | City of Hope Medical Center | |
| Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | NCT01673217 | Recurrent Fallo... Recurrent Ovari... Recurrent Prima... | decitabine NY-ESO-1 peptid... pegylated lipos... sargramostim incomplete Freu... immunohistochem... liquid chromato... mass spectromet... reverse transcr... laboratory biom... DNA methylation... enzyme-linked i... | 18 Years - | Roswell Park Cancer Institute | |
| Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants | NCT00900276 | Bladder Cancer Kidney Cancer Transitional Ce... Urethral Cancer | immunologic tec... laboratory biom... mass spectromet... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| High-Dose Methotrexate in Treating Young Patients With Solid Tumors | NCT00513981 | Brain and Centr... Sarcoma Unspecified Chi... | leucovorin calc... methotrexate mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | NCT01673217 | Recurrent Fallo... Recurrent Ovari... Recurrent Prima... | decitabine NY-ESO-1 peptid... pegylated lipos... sargramostim incomplete Freu... immunohistochem... liquid chromato... mass spectromet... reverse transcr... laboratory biom... DNA methylation... enzyme-linked i... | 18 Years - | Roswell Park Cancer Institute | |
| Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer | NCT00354679 | Esophageal Canc... | bevacizumab cisplatin irinotecan hydr... proteomic profi... diagnostic labo... mass spectromet... adjuvant therap... neoadjuvant the... therapeutic con... radiation thera... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer | NCT00892515 | Breast Cancer Healthy, no Evi... | exercise interv... counseling inte... gas chromatogra... immunoenzyme te... immunologic tec... laboratory biom... mass spectromet... physiologic tes... questionnaire a... survey administ... dual x-ray abso... magnetic resona... study of high r... | 18 Years - 35 Years | Abramson Cancer Center at Penn Medicine | |
| Transcriptional Map of Ovarian Cancer at the Single Cell Level | NCT05030805 | Ovarian Cancer | 18 Years - 80 Years | University Hospital, Strasbourg, France | ||
| Transcriptional Map of Ovarian Cancer at the Single Cell Level | NCT05030805 | Ovarian Cancer | 18 Years - 80 Years | University Hospital, Strasbourg, France | ||
| Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00575393 | Lung Cancer | gold sodium thi... gene expression... fluorine F 18 f... mass spectromet... pharmacological... | 18 Years - 120 Years | Mayo Clinic | |
| Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia | NCT01385150 | Leukemia | mutation analys... protein analysi... laboratory biom... liquid chromato... mass spectromet... | 17 Years - 60 Years | Eastern Cooperative Oncology Group | |
| Finding New Targets by Proteomic Approaches (InnovRT1) | NCT04868799 | ATRT | Mass spectromet... | - 17 Years | Assistance Publique - Hôpitaux de Paris | |
| Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 | NCT00753207 | Breast Cancer | epirubicin hydr... lapatinib ditos... biomarker analy... immunohistochem... liquid chromato... mass spectromet... | 18 Years - 120 Years | Cancer Trials Ireland | |
| Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps | NCT00898378 | Colorectal Canc... Healthy, no Evi... Precancerous Co... | gene expression... polymerase chai... polymorphism an... protein express... proteomic profi... gas chromatogra... laboratory biom... liquid chromato... mass spectromet... questionnaire a... | 18 Years - | Indiana University | |
| Pharmacokinetics of Dactinomycin in Young Patients With Cancer | NCT00900354 | Unspecified Chi... | molecular genet... mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105 | NCT00959244 | Breast Cancer | high performanc... laboratory biom... mass spectromet... medical chart r... | 19 Years - | University of Nebraska | |
| Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery | NCT00601913 | Head and Neck C... | erlotinib hydro... protein analysi... western blottin... immunohistochem... laboratory biom... liquid chromato... mass spectromet... neoadjuvant the... therapeutic con... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery | NCT00601913 | Head and Neck C... | erlotinib hydro... protein analysi... western blottin... immunohistochem... laboratory biom... liquid chromato... mass spectromet... neoadjuvant the... therapeutic con... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer | NCT00569543 | Breast Cancer | high performanc... laboratory biom... mass spectromet... medical chart r... | 19 Years - | University of Nebraska | |
| Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? | NCT03207074 | Endometrial Neo... Endometrial Can... Endometrial Hyp... Endometrial Dis... | iKnife i.e. Rap... | 18 Years - | Imperial College London | |
| Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction | NCT00540982 | Lung Cancer Unspecified Adu... | indocyanine gre... lidocaine vinorelbine dit... high performanc... intracellular f... liquid chromato... mass spectromet... pharmacological... | 18 Years - 120 Years | City of Hope Medical Center | |
| Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma | NCT01365962 | Sarcoma | gene expression... immunohistochem... laboratory biom... mass spectromet... | - | Children's Oncology Group | |
| Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment | NCT00909831 | Unspecified Adu... | hydroxychloroqu... temsirolimus electron micros... high performanc... immunologic tec... laboratory biom... mass spectromet... pharmacological... autophagy inhib... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment | NCT03401957 | Colorectal Canc... Drug Resistance Mass Spectromet... RAS-RAF Pathway... | Cetuximab liquid biopsy | 20 Years - 90 Years | National Health Research Institutes, Taiwan | |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer | NCT00900094 | Breast Cancer Colorectal Canc... Esophageal Canc... Liver Cancer Lung Cancer Ovarian Cancer Pancreatic Canc... | fluorescence in... polymerase chai... protein express... immunohistochem... laboratory biom... mass spectromet... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma | NCT01366170 | Lymphoma | microarray anal... protein express... western blottin... flow cytometry immunohistochem... laboratory biom... mass spectromet... | - 20 Years | Children's Oncology Group | |
| Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105 | NCT00959244 | Breast Cancer | high performanc... laboratory biom... mass spectromet... medical chart r... | 19 Years - | University of Nebraska | |
| Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study | NCT03432429 | Breast Cancer Surgery | REIMS iKnife | 18 Years - | Imperial College London | |
| Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00825201 | Ovarian Cancer Peritoneal Cavi... Unspecified Adu... | paclitaxel albu... liquid chromato... mass spectromet... pharmacological... laboratory biom... | 19 Years - | City of Hope Medical Center | |
| Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants | NCT00433485 | Neoplastic Synd... Non-melanomatou... | sirolimus comparative gen... gene expression... microarray anal... protein express... proteomic profi... laboratory biom... mass spectromet... biopsy | 18 Years - 120 Years | Yale University | |
| Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease | NCT00813878 | Breast Cancer | protein analysi... protein express... proteomic profi... diagnostic labo... immunohistochem... liquid chromato... mass spectromet... fine-needle asp... needle biopsy radiomammograph... | 18 Years - 120 Years | City of Hope Medical Center | |
| Mass Spectrometry in Single Bladder Cancer Cells | NCT03639090 | Bladder Cancer | mass spectromet... | 30 Years - 99 Years | University of Oklahoma | |
| Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases | NCT00738335 | Lung Cancer Metastatic Canc... | erlotinib hydro... immunoenzyme te... laboratory biom... liquid chromato... mass spectromet... pharmacological... stereotactic ra... | 18 Years - | University of California, San Francisco | |
| Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers | NCT00897234 | Lung Cancer | Mass Spectromet... | 18 Years - | University of Minnesota | |
| Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study | NCT03432429 | Breast Cancer Surgery | REIMS iKnife | 18 Years - | Imperial College London |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
